An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease (Q28581962)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease (English)

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Shyamala Mruthinti

2

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

William David Hill

3

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Scott J Webster

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Jerry J Buccafusco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

14 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

published in

NeuroMolecular Medicine

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

14

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

2

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

119-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12017-012-8176-z

25 January 2020

exact match

0 references

cites work

Forecasting the global burden of Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

The possible role of the immune system in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Local neuroinflammation and the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Development of murine (OC-147) and human (H-106) monoclonal antibodies reactive with a 53-kDa ovarian tumor-associated antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Relationship Between the Induction of RAGE Cell-Surface Antigen and the Expression of Amyloid Binding Sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Cytotoxicity of Abeta1-42, RAGE23-54, and an Abeta-RAGE complex in PC-12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Recent developments in Alzheimer's disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

New directions for frontotemporal dementia drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Anti-RAGE and Abeta immunoglobulin levels are related to dementia level and cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Worldwide variation in the doubling time of Alzheimer's disease incidence rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8176-Z

Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions

21 January 2018

1 reference

12 December 2020

Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease

1 reference

12 December 2020

Inflammation, autotoxicity and Alzheimer disease

1 reference

12 December 2020

Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS.

1 reference

12 December 2020

The psychotic phenomenon in probable Alzheimer's disease: a positron emission tomography study.

1 reference

12 December 2020

Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

1 reference

12 December 2020

Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy

1 reference

12 December 2020

Autoimmunity in Alzheimer's disease as evidenced by plasma immunoreactivity against RAGE and Abeta42: complication of diabetes

1 reference

12 December 2020

10.1007/S12017-012-8176-Z

Identifiers

DOI

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

25 January 2020

0 references

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415896%20AND%20SRC:MED&resulttype=core&format=json